Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial ; volume:10 ; number:1 ; day:19 ; month:2 ; year:2010 ; pages:1-6 ; date:12.2010
BMC gastroenterology ; 10, Heft 1 (19.2.2010), 1-6, 12.2010
- Contributor
-
Mecenate, Fabrizio
Pellicelli, Adriano M.
Barbaro, Giuseppe
Romano, Mario
Barlattani, Angelo
Mazzoni, Ettore
Bonaventura, Maria Elena
Nosotti, Lorenzo
Arcuri, Pasquale
Picardi, Antonio
Barbarini, Giorgio
D'Ambrosio, Cecilia
Paffetti, Amerigo
Andreoli, Arnaldo
Soccorsi, Fabrizio
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-10-21
- URN
-
urn:nbn:de:1111-201607154012
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mecenate, Fabrizio
- Pellicelli, Adriano M.
- Barbaro, Giuseppe
- Romano, Mario
- Barlattani, Angelo
- Mazzoni, Ettore
- Bonaventura, Maria Elena
- Nosotti, Lorenzo
- Arcuri, Pasquale
- Picardi, Antonio
- Barbarini, Giorgio
- D'Ambrosio, Cecilia
- Paffetti, Amerigo
- Andreoli, Arnaldo
- Soccorsi, Fabrizio
- SpringerLink (Online service)
Other Objects (12)
Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo
Cleo